Acupuncture helps Pain in US Urban Primary Care

acupuncture helps pain
New York: Acupuncture helps pain

A randomised trial in the US has shown that for both individual and group sessions given in primary care settings, acupuncture helps pain and improves physical function in patients with chronic musculoskeletal conditions. Researchers from the Albert Einstein College of Medicine enrolled 779 adults, mean age 55, attending six inner city primary care centres in the New York Bronx district for neck, back or osteoarthritis pain. Participants received weekly individualised acupuncture on either a group or one-to-one basis, for 12 weeks, in addition to usual care.

At the outset, 60% of participants reported poor to fair health, whilst 37% were unable to work due to disability. In the Bronx, nearly one third of the population lives below the poverty line.

After 12 weeks, 37% of patients in the individual treatment arm, and 30% of those in the group treatment arm, had a greater than 30% improvement in pain interference. Pain severity showed clinically meaningful improvements in over 30% of patients, and global physical health improved in approximately 60% of patients. Opiate use declined in the individual arm, but not in the group arm.

The research team concluded that their results demonstrate that individual and group acupuncture can be offered safely in the community health centre setting, that acceptability to patients and clinicians is very high, and that a substantial proportion of patients with chronic pain will have clinically significant improvement in both pain and overall physical health. Acupuncture therapy should be offered as part of pain care to underserved populations in the primary care setting. 

(Individual vs. Group Delivery of Acupuncture Therapy for Chronic Musculoskeletal Pain in Urban Primary Care – a Randomized Trial. Journal of General Internal Medicine, 19 February 2020.)

Acupuncture for Musculoskeletal Pain

University researchers in Greece studying acupuncture for musculoskeletal pain of a chronic nature, have shown pain intensity, disability and salivary cortisol levels, can all be reduced. Thirty patients were randomly assigned to receive either physiotherapy, acupuncture, or sham ultrasound therapy for ten sessions.

Acupuncture was associated with greater decreases in pain intensity and disability than either physiotherapy or sham ultrasound. Significant decreases in salivary cortisol levels were observed in all three groups.

(The effect of treatment regimens on salivary cortisol levels in patients with chronic musculoskeletal disorders. Journal of Bodywork & Movement Therapies, January 2020.)

Electroacupuncture eases Pain after Kidney Stone Removal

Acupuncture in Exeter: electroacupuncture eases pain after kidney stone removal. American researchers have shown electroacupuncture significantly reduces pain after kidney stone removal by percutaneous nephrolithotomy. They randomised 51 patients to receive either electroacupuncture, sham electroacupuncture or no acupuncture. Flank and abdomen pain was lower at all time points in the electroacupuncture group compared with the other two groups. Immediate post-operative opioid use was also lower in the electroacupuncture group, with two patients not requiring any opioids.

The researchers say that electroacupuncture significantly reduces pain and opioid usage without any adverse effects, and this promising treatment warrants further investigation.

(A Randomized, Double-Blind, Sham-Controlled Study Assessing Electroacupuncture for the Management of Postoperative Pain after Percutaneous Nephrolithotomy. Journal of Endourology, March 2019.)

Pain in the Emergency Department helped by Acupuncture

Pain Authors of a large American pilot study have concluded acupuncture is a feasible and beneficial, non-pharmacological option for treating pain in the emergency department. The researchers’ aim was to determine the feasibility of employing an acupuncturist in an urban emergency department, to provide an acute pain management option.

Of 706 patients with acute pain, 379 agreed to try acupuncture in the emergency department of a Milwaukee hospital. Their mean pain scores decreased significantly (from 6.5 to 3.4), as did their levels of stress, anxiety and nausea. The treatment was well received.

One author reported, “We believe this research is very important because America is currently in the throes of a pain management and opioid crisis. What contributed to this crisis was a belief that new technologies, surgical procedures, and the liberal use of opioids would be the answers to controlling human pain. As we now know, these strategies have not proven efficacious in mitigating pain, suffering, and disability to the extent the public was led to believe.”

(ED Acupuncture: Feasibility, Acceptability, and Impact on Pain. American Pain Society Annual Meeting, April 2019.)

Acupuncture for Chronic Pain in US Medicaid Scheme

Acupuncture for chronic pain. Research commissioned by the US State of Vermont shows that acupuncture is effective for chronic pain and offers a wide array of other benefits, for patients on low incomes and treated under the government-funded Medicaid scheme. Previous studies have shown that this population is hampered in its access to non-pharmacological treatments, by lack of health insurance. In a pragmatic randomised trial, Medicaid patients with chronic pain were offered up to 12 acupuncture sessions over a 60 day period. This resulted in 156 patients (111 women & 45 men) receiving an average 8.2 treatments.

– There were significant improvements in pain intensity, pain interference, physical function, fatigue, anxiety, depression, sleep and social isolation.
– 57% of patients using non-opioid analgesics reported reductions in use.
– 32% of patients using opioid analgesics reported reductions in use.
– 74% of employed patients reported improved capacity to work.
– 96% of patients would recommend acupuncture to others with chronic pain.

(Acupuncture for Chronic Pain in the Vermont Medicaid Population: A Prospective, Pragmatic Intervention Trial. Global Advances in Health & Medicine, April 2018.)